Beranda › Kanker Prostat Resisten Kastrasi › Tennessee
Uji klinis Kanker Prostat Resisten Kastrasi di Tennessee
5 studi untuk Kanker Prostat Resisten Kastrasi mencari peserta di lokasi di Tennessee.
Kota di Tennessee
Teks studi resmi (Bahasa Inggris)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Tennessee Cancer Specialists, Knoxville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Tennessee Oncology - Chattanooga, Chattanooga
- Tennessee Oncology Nashville, Nashville
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT07164443A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- Tennessee Oncology, Nashville
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 24 Sep 2026 · NCT07719361A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- The West Clinic, PLLC dba West Cancer Center ( Site 0005), Germantown
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06863272Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Sarah Cannon Research, Nashville
Menerima pesertaFase 1
Usia 18 hingga 100 · Pria · Diperbarui 13 Agu 2026 · NCT05519449Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.